Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.00705
+0.00055 (8.46%)
At close: May 12, 2026
Petros Pharmaceuticals Company Description
Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies.
The company is based in New York, New York.
Petros Pharmaceuticals, Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Fady Boctor |
Contact Details
Address: 1185 Avenue of the Americas New York, New York 10036 United States | |
| Phone | 973 242 0005 |
| Website | petrospharma.com |
Stock Details
| Ticker Symbol | PTPI |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US71678J1007 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Joshua N. Silverman | Executive Chairman of the Board |
| Fady Boctor M.B.A. | President and Chief Commercial Officer |
| Mitchell S. Arnold M.B.A. | Vice President of Finance and Chief Accounting Officer |